FacebookLinkedInX

Resources

Resources2021-04-28T14:16:20-04:00

RESOURCES

Browse our Resources

Use the below filters and search to find publications including Amicus Briefs, Testimony and Comments, IPO Law Journal Articles, and the IPO Federal Circuit Summaries™.

TITLE PUBLISHED CATEGORY
Letter to U.S. House Committee on the Judiciary Regarding Hearing on the ETHIC Act and Skinny Labels, Big Savings Act June 02, 2026 Testimony and Comments
TRADE SECRET OWNER VIOLATED STATUTE OF LIMITATIONS* * Insulet Corp. v. EOFlow, Co. Ltd., 25-1807 May 28, 2026 IPO Federal Circuit Summaries
PLAINTIFF HAS THE RIGHT TO PURSUE UNJUST ENRICHMENT UNDER DTSA AND STATE TRADE SECRETS* * Law Versata Software, LLC v. Ford Motor Co., 24-1140, 24-1206, 24-1234 May 22, 2026 IPO Federal Circuit Summaries
LICENSOR’S RETAINED RIGHTS CONFERRED CONSTITUTIONAL STANDING* A.L.M. Holding Co. v. Zydex Indus. Private Ltd., 25-1317 May 19, 2026 IPO Federal Circuit Summaries
DISTRICT COURT ERRED IN AWARDING FEES AGAINST PATENT OWNER IN INFRINGEMENT CASE* * mCom IP, LLC v. City Nat’l Bank of Fla., 24-2089 May 15, 2026 IPO Federal Circuit Summaries
DISTRICT COURT CORRECTLY CONSTRUED PATENT CLAIMS AS MEASURING PH AT THE STANDARD TEMPERATURE* * Actelion Pharms. Ltd. v. Mylan Pharms. Inc., 24-1641 May 13, 2026 IPO Federal Circuit Summaries
IPO Comments on USPTO Supplemental Guidance Related to Design Patent Applications for Computer-Generated Interfaces and Icons May 12, 2026 Testimony and Comments
ITC DID NOT IMPROPERLY CONSTRUE CLAIM LIMITATION DURING INITIAL DETERMINATION* * Bissell, Inc. v. Int’l Trade Comm’n, 24-1509, 24-1709 May 11, 2026 IPO Federal Circuit Summaries
Resolution on Legislative Amendment to Anti-Cybersquatting Consumer Protection Act May 07, 2026 Board Resolutions
Resolution on Patent Subject Matter Eligibility May 07, 2026 Board Resolutions
USE OF TERM “ABOUT” IN CLAIMED RANGE RENDERED PATENT INDEFINITE* * Enviro Tech Chemical Servs., Inc. v. Safe Foods Corp., 24-2160 May 05, 2026 IPO Federal Circuit Summaries
JUDICIAL REVIEW OF IPR REAL PARTY IN INTEREST DETERMINATION BARRED UNDER 35 U.S.C. § 314(D)* * Fed. Express Corp. v. Qualcomm Incorp., 24-1236 April 29, 2026 IPO Federal Circuit Summaries
OPTIMIZED DIGITAL COMMUNICATION CONSTELLATIONS WERE NOT PATENT-ELIGIBLE SUBJECT MATTER* * Constellation Designs, LLC v. LG Elecs. Inc., 24-1822 April 28, 2026 IPO Federal Circuit Summaries
IPO’s Request to the National Data Administration for an Extension of Time re: Comments on the “Guidelines for Data Property Rights Registration (Trial)” April 17, 2026 Testimony and Comments
PRODUCT FEATURES AND PROCEDURES PREVIOUSLY DISCLOSED IN PATENTS WERE INELIGIBLE FOR TRADE SECRET PROTECTION* * Int’l Med. Devices, Inc. v. Cornell, 25-1580, 25-1605 April 17, 2026 IPO Federal Circuit Summaries
NON-HUMANIZED ANTIBODIES WERE REPRESENTATIVE OF GENUS OF HUMANIZED ANTIBODIES* * Teva Pharms. Int’l GmbH v. Eli Lilly & Co., 24-1094 April 16, 2026 IPO Federal Circuit Summaries
PRE-TRIAL STIPULATION PROPERLY ESTABLISHED U.S. NEXUS UNDER SECTION 271* VLSI Tech. LLC v. Intel Corp., 24-1772 April 14, 2026 IPO Federal Circuit Summaries
SOURCE CODE COMMANDS ARE NOT HEARSAY* Definitive Holdings v. Powerteq, 24-1761 April 14, 2026 IPO Federal Circuit Summaries
USPTO’s RELIANCE ON PARTIES’ STIPULATION AGREEMENT WAS HARMLESS ERROR * Fuente Marketing Ltd. v. Vaporous Techs., LLC, 24-1460  April 08, 2026 IPO Federal Circuit Summaries
Debunking Biopharmaceutical Patent Myths: An Evidence-Based Analysis April 07, 2026 IPO Law Journal
APPELLANT FAILED TO SHOW INJURY OF FACT AS TO SUBSTITUTED CLAIMS* ironSource LTD. v. Digital Turbine, Inc., 24-1831 April 07, 2026 IPO Federal Circuit Summaries
COINVENTORS MUST BE PROVIDED NOTICE AND OPPORTUNITY FOR HEARING UNDER SECTION 256(B)* Fortress Iron, LP v. Digger Specialties, Inc., 24, 2313 April 02, 2026 IPO Federal Circuit Summaries
IPO Comments to CNIPA on Draft Amendments to the Measures for the Administration of Patent Priority Examination March 27, 2026 Testimony and Comments
You Can’t (Always) Claim What You Didn’t Describe: U.S. and European Perspectives on Chemical Patents March 26, 2026 IPO Law Journal
MANDATORY STAY OF PROCEEDINGS UNDER 28 U.S.C. § 1659(A)(2) MUST BE FILED WITHIN 30 DAYS OF ORIGINALLY FILED COMPLAINT* * Ascendis Pharma v. Biomarin Pharma. Inc., 26-1026 March 26, 2026 IPO Federal Circuit Summaries
SECTION 337 DOES NOT REQUIRE AN EXACT ARTICLE TO FULFILL THE DOMESTIC INDUSTRY REQUIREMENT* Apple Inc. v. Int’l Trade Comm’n, 24-1285 March 19, 2026 IPO Federal Circuit Summaries
METHOD OF VIRUS DETECTION WAS AN INELIGIBLE ABSTRACT IDEA* Trustees of Columbia Univ. v. Gen Digital Inc., 24-1243 March 11, 2026 IPO Federal Circuit Summaries
ATTORNEY-CLIENT PRIVILEGE NOT AUTOMATICALLY TERMINATED BY ALLEGED CONFLICT OF INTEREST* Trustees of Columbia Uni. v. Gen Digital Inc., 24-1244 March 11, 2026 IPO Federal Circuit Summaries
DISTRICT COURT ERRONEOUSLY DISCOUNTED CORRESPONDING STRUCTURE THAT PERFORMED THE CLAIMED FUNCTION* Gramm v. Deere & Co., 24-1598 March 11, 2026 IPO Federal Circuit Summaries
IPO Amicus Brief in Hikma Pharmaceuticals USA Inc., v. Amarin Pharma, Inc., 24-889 March 09, 2026 Amicus Briefs
FORFEITURE PRINCIPLES APPLY WHERE SECTION 256 CORRECTION HAS ISSUED* Implicit LLC v. Sonos Inc., 20-1173, 20-1174 March 09, 2026 IPO Federal Circuit Summaries
IPO Comments on Draft Agreement on Cross-Border Aspects of Client-Patent-Attorney Privilege March 06, 2026 Testimony and Comments
DISTRICT COURT IMPROPERLY EXCLUDED DAMAGES EVIDENCE WITH A CAUSAL CONNECTION TO THE ACCUSED PRODUCT* Exafer LTD v. Microsoft Corp., 24-2296 March 06, 2026 IPO Federal Circuit Summaries
SEPARATE CORRESPONDING STRUCTURES ARE INHERENT IN THE CONSTRUCTION OF SEPARATELY LISTED LIMITATIONS* * March 06, 2026 IPO Federal Circuit Summaries
DISTRICT COURT ERRONEOUSLY DETERMINED INVENTOR ACTED WITH SPECIFIC INTENT TO DEFRAUD USPTO* * Global Tubing LLC v. Tenaris Coiled Tubes LLC, 23-1882, 23-1883 February 26, 2026 IPO Federal Circuit Summaries
IPO Post-Hearing Statement to Special 301 Subcommittee February 25, 2026 Testimony and Comments
IPO Comments to India Department for Promotion of Industry and Internal Trade (DPIIT) on its “Concept Note: Proposed Amendment to the Designs Act, 2000″ February 20, 2026 Testimony and Comments
DISTRICT COURT 1010 ANALYSIS FAILED TO CONSIDER COMPOSITION AS A WHOLE* * REGENXBIO Inc. v. Sarepta Therapeutics, Inc., 24-1408 February 20, 2026 IPO Federal Circuit Summaries
MEANS-PLUS-FUNCTION EXPERT TESTIMONY FAILED TO PROVIDE SUFFICIENT EVIDENCE OF STRUCTURAL EQUIVALENCE* * Genuine Enabling Tech., LLC v. Sony Grp. Corp., 24-1686 February 19, 2026 IPO Federal Circuit Summaries
DISTRICT COURT PROPERLY ADMITTED RELIABLE EXPERT TESTIMONY UNDER FRE 702* * Willis Elec. Co., Ltd. v. Polygroup Ltd., 24-2118 February 17, 2026 IPO Federal Circuit Summaries
Load More